Mechanical Stiffness Promotes Skin Fibrosis Through FAPα-AKT Signaling Pathway.

Jiahao He,Bin Fang,Shengzhou Shan,Qingfeng Li
DOI: https://doi.org/10.1016/j.jdermsci.2023.12.004
IF: 5.408
2024-01-01
Journal of Dermatological Science
Abstract:Background: Myofibroblasts contribute to the excessive production, remodeling and cross-linking of the extracellular matrix that characterizes the progression of skin fibrosis. An important insight into the pathogenesis of tissue fibrosis has been the discovery that increased matrix stiffness during fibrosis progression is involved in myofibroblast activation. However, mechanistic basis for this phenomenon remains elusive. Objective: To explore the role of fibroblast activation protein-alpha (FAP alpha) in mechanical stiffness-induced skin fibrosis progression. Methods: RNA-seq was performed to compare differential genes of mouse dermal fibroblasts (MDFs) grown on low or high stiffness plates. This process identified FAP alpha, which is a membrane protein usually overexpressed in activated fibroblasts, as a suitable candidate. In vitro assay, we investigate the role of FAP alpha in mechanical stiffness-induced MDFs activation and downstream pathway. By establishing mouse skin fibrosis model and intradermally administrating FAP alpha adeno-associated virus (AAV) or a selective Fap inhibitor FAPi, we explore the role of FAP alpha in skin fibrosis in vivo. Results: We show that FAP alpha, a membrane protein highly expressed in myofibroblasts of skin fibrotic tissues, is regulated by increased matrix stiffness. Genetic deletion or pharmacological inhibition of FAP alpha significantly inhibits mechanical stiffness-induced activation of myofibroblasts in vitro. Mechanistically, FAP alpha promotes myofibroblast activation by stimulating the PI3K-Akt pathway. Furthermore, we showed that administration of the inhibitor FAPi or FAP alpha targeted knockdown ameliorated the progression of skin fibrosis. Conclusion: Taken together, we identify FAP alpha as an important driver of mechanical stiffness-induced skin fibrosis and a potential therapeutic target for the treatment of skin fibrosis. (c) 2023 The Author(s). Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
What problem does this paper attempt to address?